Literature DB >> 22797397

Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.

Stephen Kucera1, Barbara A Centeno, Gregory Springett, Mokenge P Malafa, Yian Ann Chen, Jill Weber, Jason Klapman.   

Abstract

CONTEXT: Cyst fluid CEA concentration>192 ng/mL has proven accurate to differentiate mucinous from non-mucinous pancreatic cystic neoplasms. It is unclear whether the degree of cyst fluid CEA elevation is predictive of malignant behavior in IPMNs.
OBJECTIVES: To determine whether elevated cyst fluid CEA concentrations were predictive of invasive cancer.
DESIGN: Cross sectional study.
SETTING: Single National Cancer Institute comprehensive cancer care center experience. PATIENTS: 47 patients underwent preoperative EUS-FNA with cyst fluid analysis and surgical resection of an IPMN over a 9 year period. MAIN OUTCOME MEASUREMENTS: Cyst fluid CEA concentrations among the four grades associated with IPMN (low grade dysplasia, moderate dysplasia, high grade dysplasia, and invasive cancer).
RESULTS: The mean±standard deviation cyst fluid CEA concentration increased as the pathology progressed from low grade dysplasia (1,261±1,679 ng/mL) to moderate dysplasia (7,171±22,210 ng/mL) to high grade dysplasia (10,807±36,203 ng/mL). However, the mean CEA level decreased (462±631 ng/mL) once invasive cancer developed (P=0.869). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of a cyst fluid CEA concentration greater than 200 ng/mL for the diagnosis of malignant IPMN (cases of high grade dysplasia and invasive IPMN) was 52.4%, 42.3%, 42.3%, 52.4% and 46.8%, respectively. LIMITATIONS: Single center experience, small patient numbers, retrospective data collection.
CONCLUSION: The degree of cyst fluid CEA elevation is a poor predictor of malignant degeneration within IPMNs. Clinical management decisions regarding surgical resection should not be based upon degree of cyst fluid CEA elevation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797397     DOI: 10.6092/1590-8577/664

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  11 in total

1.  Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Mohammad A Al Efishat; Marc A Attiyeh; Anne A Eaton; Mithat Gönen; Denise Prosser; Anna E Lokshin; Carlos Fernández-Del Castillo; Keith D Lillemoe; Cristina R Ferrone; Ilaria Pergolini; Mari Mino-Kenudson; Neda Rezaee; Marco Dal Molin; Matthew J Weiss; John L Cameron; Ralph H Hruban; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Christopher L Wolfgang; Peter J Allen
Journal:  Ann Surg       Date:  2018-08       Impact factor: 12.969

Review 2.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 3.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

4.  Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.

Authors:  Christopher J DiMaio; Frances Weis-Garcia; Emilia Bagiella; Laura H Tang; Peter J Allen
Journal:  Gastrointest Endosc       Date:  2015-09-25       Impact factor: 9.427

Review 5.  Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms.

Authors:  Alkiviadis Efthymiou; Thrasyvoulos Podas; Emmanouil Zacharakis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  Sensitivity of EUS and ERCP Endoscopic Procedures in the Detection of Pancreatic Cancer During Preoperative Staging Correlated with CT and CT Angiography Imaging Methods.

Authors:  Zora Vukobrat-Bijedic; Azra Husic-Selimovic; Nina Bijedic; Srdjan Gornjakovic; Amela Sofic; Bisera Gogov; Ivana Bjelogrlic; Amila Mehmedovic; Sanjin Glavas
Journal:  Acta Inform Med       Date:  2014-06-15

7.  Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation.

Authors:  Cameron Beech; Mollie Freedman-Weiss; Ronald Salem; Dhanpat Jain; Xuchen Zhang
Journal:  Gastroenterology Res       Date:  2019-08-25

Review 8.  The utilization of imaging features in the management of intraductal papillary mucinous neoplasms.

Authors:  Stefano Palmucci; Claudia Trombatore; Pietro Valerio Foti; Letizia Antonella Mauro; Pietro Milone; Roberto Milazzotto; Rosalia Latino; Giacomo Bonanno; Giuseppe Petrillo; Antonio Di Cataldo
Journal:  Gastroenterol Res Pract       Date:  2014-08-19       Impact factor: 2.260

9.  Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines.

Authors:  Martha B Pitman; Barbara A Centeno; Syed Z Ali; Muriel Genevay; Ed Stelow; Mari Mino-Kenudson; Carlos Fernandez-Del Castillo; C Max Schmidt; William R Brugge; Lester J Layfield
Journal:  Cytojournal       Date:  2014-06-02       Impact factor: 2.091

10.  Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy.

Authors:  Ananya Das; William Brugge; Girish Mishra; Dennis M Smith; Mankanwal Sachdev; Eric Ellsworth
Journal:  Endosc Int Open       Date:  2015-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.